Abstract
Summary
Subdermal contraceptive implants involve the delivery of a steroid progestin from polymer capsules or rods placed under the skin. The hormone diffuses out slowly at a stable rate, providing contraceptive effectiveness for 1-5 years. The period of protection depends upon the specific progestin and the type of polymer.
LPI (LP Information)' newest research report, the “Subdermal Contraceptive Implants Industry Forecast” looks at past sales and reviews total world Subdermal Contraceptive Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Subdermal Contraceptive Implants sales for 2023 through 2029. With Subdermal Contraceptive Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subdermal Contraceptive Implants industry.
This Insight Report provides a comprehensive analysis of the global Subdermal Contraceptive Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subdermal Contraceptive Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subdermal Contraceptive Implants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subdermal Contraceptive Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subdermal Contraceptive Implants.
The global Subdermal Contraceptive Implants market size is projected to grow from US$ 635.8 million in 2022 to US$ 984.3 million in 2029; it is expected to grow at a CAGR of 984.3 from 2023 to 2029.
United States market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Subdermal Contraceptive Implants players cover Bayer AG, Merck and Shanghai Dahua Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Subdermal Contraceptive Implants market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Jadelle
Sino-implant
Implanon
Nexplanon
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Merck
Shanghai Dahua Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Subdermal Contraceptive Implants market?
What factors are driving Subdermal Contraceptive Implants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subdermal Contraceptive Implants market opportunities vary by end market size?
How does Subdermal Contraceptive Implants break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Subdermal Contraceptive Implants Industry Forecast” looks at past sales and reviews total world Subdermal Contraceptive Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Subdermal Contraceptive Implants sales for 2023 through 2029. With Subdermal Contraceptive Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subdermal Contraceptive Implants industry.
This Insight Report provides a comprehensive analysis of the global Subdermal Contraceptive Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subdermal Contraceptive Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subdermal Contraceptive Implants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subdermal Contraceptive Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subdermal Contraceptive Implants.
The global Subdermal Contraceptive Implants market size is projected to grow from US$ 635.8 million in 2022 to US$ 984.3 million in 2029; it is expected to grow at a CAGR of 984.3 from 2023 to 2029.
United States market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Subdermal Contraceptive Implants players cover Bayer AG, Merck and Shanghai Dahua Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Subdermal Contraceptive Implants market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Jadelle
Sino-implant
Implanon
Nexplanon
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bayer AG
Merck
Shanghai Dahua Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Subdermal Contraceptive Implants market?
What factors are driving Subdermal Contraceptive Implants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Subdermal Contraceptive Implants market opportunities vary by end market size?
How does Subdermal Contraceptive Implants break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Subdermal Contraceptive Implants Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Subdermal Contraceptive Implants by Country/Region, 2018, 2022 & 2029
2.2 Subdermal Contraceptive Implants Segment by Type
2.2.1 Jadelle
2.2.2 Sino-implant
2.2.3 Implanon
2.2.4 Nexplanon
2.3 Subdermal Contraceptive Implants Sales by Type
2.3.1 Global Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
2.3.2 Global Subdermal Contraceptive Implants Revenue and Market Share by Type (2018-2023)
2.3.3 Global Subdermal Contraceptive Implants Sale Price by Type (2018-2023)
2.4 Subdermal Contraceptive Implants Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Subdermal Contraceptive Implants Sales by Application
2.5.1 Global Subdermal Contraceptive Implants Sale Market Share by Application (2018-2023)
2.5.2 Global Subdermal Contraceptive Implants Revenue and Market Share by Application (2018-2023)
2.5.3 Global Subdermal Contraceptive Implants Sale Price by Application (2018-2023)
3 Global Subdermal Contraceptive Implants by Company
3.1 Global Subdermal Contraceptive Implants Breakdown Data by Company
3.1.1 Global Subdermal Contraceptive Implants Annual Sales by Company (2018-2023)
3.1.2 Global Subdermal Contraceptive Implants Sales Market Share by Company (2018-2023)
3.2 Global Subdermal Contraceptive Implants Annual Revenue by Company (2018-2023)
3.2.1 Global Subdermal Contraceptive Implants Revenue by Company (2018-2023)
3.2.2 Global Subdermal Contraceptive Implants Revenue Market Share by Company (2018-2023)
3.3 Global Subdermal Contraceptive Implants Sale Price by Company
3.4 Key Manufacturers Subdermal Contraceptive Implants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subdermal Contraceptive Implants Product Location Distribution
3.4.2 Players Subdermal Contraceptive Implants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Subdermal Contraceptive Implants by Geographic Region
4.1 World Historic Subdermal Contraceptive Implants Market Size by Geographic Region (2018-2023)
4.1.1 Global Subdermal Contraceptive Implants Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Subdermal Contraceptive Implants Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Subdermal Contraceptive Implants Market Size by Country/Region (2018-2023)
4.2.1 Global Subdermal Contraceptive Implants Annual Sales by Country/Region (2018-2023)
4.2.2 Global Subdermal Contraceptive Implants Annual Revenue by Country/Region (2018-2023)
4.3 Americas Subdermal Contraceptive Implants Sales Growth
4.4 APAC Subdermal Contraceptive Implants Sales Growth
4.5 Europe Subdermal Contraceptive Implants Sales Growth
4.6 Middle East & Africa Subdermal Contraceptive Implants Sales Growth
5 Americas
5.1 Americas Subdermal Contraceptive Implants Sales by Country
5.1.1 Americas Subdermal Contraceptive Implants Sales by Country (2018-2023)
5.1.2 Americas Subdermal Contraceptive Implants Revenue by Country (2018-2023)
5.2 Americas Subdermal Contraceptive Implants Sales by Type
5.3 Americas Subdermal Contraceptive Implants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subdermal Contraceptive Implants Sales by Region
6.1.1 APAC Subdermal Contraceptive Implants Sales by Region (2018-2023)
6.1.2 APAC Subdermal Contraceptive Implants Revenue by Region (2018-2023)
6.2 APAC Subdermal Contraceptive Implants Sales by Type
6.3 APAC Subdermal Contraceptive Implants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Subdermal Contraceptive Implants by Country
7.1.1 Europe Subdermal Contraceptive Implants Sales by Country (2018-2023)
7.1.2 Europe Subdermal Contraceptive Implants Revenue by Country (2018-2023)
7.2 Europe Subdermal Contraceptive Implants Sales by Type
7.3 Europe Subdermal Contraceptive Implants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Subdermal Contraceptive Implants by Country
8.1.1 Middle East & Africa Subdermal Contraceptive Implants Sales by Country (2018-2023)
8.1.2 Middle East & Africa Subdermal Contraceptive Implants Revenue by Country (2018-2023)
8.2 Middle East & Africa Subdermal Contraceptive Implants Sales by Type
8.3 Middle East & Africa Subdermal Contraceptive Implants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subdermal Contraceptive Implants
10.3 Manufacturing Process Analysis of Subdermal Contraceptive Implants
10.4 Industry Chain Structure of Subdermal Contraceptive Implants
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subdermal Contraceptive Implants Distributors
11.3 Subdermal Contraceptive Implants Customer
12 World Forecast Review for Subdermal Contraceptive Implants by Geographic Region
12.1 Global Subdermal Contraceptive Implants Market Size Forecast by Region
12.1.1 Global Subdermal Contraceptive Implants Forecast by Region (2024-2029)
12.1.2 Global Subdermal Contraceptive Implants Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subdermal Contraceptive Implants Forecast by Type
12.7 Global Subdermal Contraceptive Implants Forecast by Application
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Subdermal Contraceptive Implants Product Portfolios and Specifications
13.1.3 Bayer AG Subdermal Contraceptive Implants Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Subdermal Contraceptive Implants Product Portfolios and Specifications
13.2.3 Merck Subdermal Contraceptive Implants Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Shanghai Dahua Pharmaceutical Co., Ltd.
13.3.1 Shanghai Dahua Pharmaceutical Co., Ltd. Company Information
13.3.2 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Product Portfolios and Specifications
13.3.3 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Shanghai Dahua Pharmaceutical Co., Ltd. Main Business Overview
13.3.5 Shanghai Dahua Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion